BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2021
View Archived Issues
CVL-231 safe in healthy volunteers; evaluation in schizophrenia patients ongoing
Read More
Studies reveal activity, mechanism of TAM kinase inhibitor PF-5807
Read More
Phase III study finds Xywav improves excessive daytime sleepiness
Read More
Observational study confirms good tolerability and efficacy of Intratect
Read More
Second pivotal study of IDP-126 achieves all coprimary endpoints with statistical significance
Read More
First patient dosed in investigator-initiated study of rigosertib in RDEB-associated SCC
Read More
Monopteros initiates phase I/Ib study of MPT-0118 in solid tumors
Read More
Phase III JUPITER-06 study of toripalimab plus chemotherapy meets primary endpoints
Read More
Medshine Discovery divulges PD-1/PD-L1 interaction inhibitors
Read More
Chinese investigators disclose HGFR and/or SRC and/or CSF1R inhibitors
Read More
Roche presents HBsAg secretion inhibitors
Read More
Alladapt initiates phase I/II Harmony Study of ADP-101
Read More
Shanghai Litedd identifies new ROR-gammaT agonists
Read More
Tolremo Therapeutics describes new DYRK1B inhibitors
Read More
Phase II trial of selective oral DHODH modulator vidofludimus in RRMS
Read More
FDA grants accelerated approval to Jemperli for dMMR endometrial cancer
Read More
ProtoKinetix resumes phase I trials of PKX-001-treated islet cells in patients with type 1 diabetes
Read More
ICAM-1 orchestrates radiotherapy abscopal effect
Read More
Discovery of JBI-1527, small molecule inhibitor of PD-L1/PD-1 interaction
Read More
OR-2805: a novel antibody targeting CD163 for the treatment of lung cancers
Read More
Zenith agrees with Astellas to study ZEN-3694 with enzalutamide in metastatic CRPC
Read More
